Intestinal infections with enteropathogenic Escherichia coli are potentially devastating and difficult to treat. Outbreaks linked to food-borne spread of the bacteria have occurred repeatedly in the US in recent years. New approaches to neutralizing the bacterial toxins responsible for the worst effects of the disease may provide lifesaving tools for clinicians (265–270 ).
This is a preview of subscription content, log in via an institution to check access.
References
Nataro, J.P. & Kaper, J.B. Diarrheagenic Escherichia coli . Clin. Microbiol. Rev. 2, 142– 201 (1998).
Centers for Disease Control and Prevention Summary of notifiable diseases, United States, 1999. Mortal. Morbid. Weekly Reports 48, 1183–1190 ( 2000).
Lingwood, C.A. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4, 147–153 ( 1996).
Paton, A.W., Morona, R. & Paton, J.C. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nature Med. 6, 265–270 ( 2000).
Kitov, P.I. et al. Shiga-like toxins neutralized by tailored multivalent carbohydrate ligands. Nature 403, 669– 672 (2000).
Domenighini, M., Magagnoli, C., Pizza, M. & Rappuoli, R. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. Mol. Microbiol. 14, 41–50 (1994).
Takeda, T., Yoshino, K., Adachi, E., Sato, Y. & Yamagata, K. In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb PK) as a specific absorbing agent of Shiga toxin 1 and 2. Microbiol. Immunol. 43, 331–337 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donnelly, J., Rappuoli, R. Blocking bacterial enterotoxins. Nat Med 6, 257–258 (2000). https://doi.org/10.1038/73095
Issue Date:
DOI: https://doi.org/10.1038/73095
- Springer Nature America, Inc.